http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101233073-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2011-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101233073-B1 |
| titleOfInvention | Pharmaceutical composition comprising a peptide having inhibitory activity against extravasation of leukocytes and metastasis inhibiting activity of cancer cells |
| abstract | The present invention provides a pharmaceutical composition for preventing or treating inflammatory diseases comprising a peptide fragment derived from CD300LG, which is a kind of a transmembrane protein, that is, a peptide selected from the group consisting of peptides consisting of amino acid sequences of SEQ ID NOs: 1 to 3; And it provides a pharmaceutical composition for inhibiting cancer metastasis. |
| priorityDate | 2011-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.